	US 11,753,465 B2
	Nucleic acids encoding polypeptides against IL-23
Marie-Ange Buyse, Merelbeke (BE)
Assigned to Ablynx N.V., Zwijnaarde (BE); and Sanofi, Paris (FR)
Filed by Ablynx N.V., Ghent-Zwijnaarde (BE); and Sanofi, Paris (FR)
Filed on Mar. 1, 2021, as Appl. No. 17/188,158.
Application 17/188,158 is a continuation of application No. 15/769,864, granted, now 10,968,271, issued on Apr. 6, 2021, previously published as PCT/EP2016/076076, filed on Oct. 28, 2016.
Claims priority of provisional application 62/248,468, filed on Oct. 30, 2015.
Prior Publication US 2021/0188967 A1, Jun. 24, 2021
Int. Cl. C07K 16/24 (2006.01); A61P 35/00 (2006.01); C07K 16/42 (2006.01); A61P 31/00 (2006.01)

CPC C07K 16/244 (2013.01) [A61P 35/00 (2018.01); A61P 31/00 (2018.01); C07K 16/4208 (2013.01); C07K 2317/22 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/569 (2013.01)]

12 Claims

1. A nucleic acid that encodes an anti-interleukin 23 (IL-23) polypeptide comprising an amino acid sequence that is chosen from the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 3.